Jak1	B-protein
expression	O
is	O
required	O
for	O
mediating	O
interleukin-4-induced	O
tyrosine	O
phosphorylation	O
of	O
insulin	O
receptor	O
substrate	O
and	O
Stat6	B-protein
signaling	B-protein
molecules	I-protein
.	O

The	O
Jak1	B-protein
,	I-protein
Jak2	I-protein
,	I-protein
Jak3	I-protein
,	I-protein
and	I-protein
Fes	I-protein
tyrosine	I-protein
kinases	I-protein
have	O
been	O
demonstrated	O
to	O
undergo	O
tyrosine	O
phosphorylation	O
in	O
response	O
to	O
interleukin	B-protein
(	I-protein
IL	I-protein
)	I-protein
-4	I-protein
stimulation	O
in	O
different	O
cell	O
systems	O
.	O

However	O
,	O
it	O
is	O
not	O
clear	O
which	O
,	O
if	O
any	O
,	O
of	O
these	O
kinases	O
are	O
responsible	O
for	O
initiating	O
IL-4-induced	O
tyrosine	O
phosphorylation	O
of	O
intracellular	B-protein
substrates	I-protein
in	O
vivo	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
have	O
utilized	O
a	O
mutant	B-cell_line
Jak1-deficient	I-cell_line
HeLa	I-cell_line
cell	I-cell_line
line	I-cell_line
,	O
E1C3	B-cell_line
,	O
and	O
its	O
parental	B-cell_line
Jak1-expressing	I-cell_line
counterpart	I-cell_line
,	O
1D4	B-cell_line
,	O
to	O
analyze	O
the	O
role	O
of	O
Jak1	B-protein
in	O
mediating	O
IL-4-induced	O
tyrosine	O
phosphorylation	O
events	O
.	O

IL-4	O
treatment	O
rapidly	O
induced	O
tyrosine	O
phosphorylation	O
of	O
insulin	B-protein
receptor	I-protein
substrate	I-protein
(	I-protein
IRS	I-protein
)	I-protein
-1	I-protein
and	O
IRS-2	B-protein
in	O
1D4	B-cell_line
but	O
not	O
in	O
E1C3	B-cell_line
cells	I-cell_line
.	O

IL-4	B-protein
-mediated	O
tyrosine	O
phosphorylation	O
of	O
Stat6	B-protein
was	O
pronounced	O
in	O
1D4	B-cell_line
cells	I-cell_line
,	O
while	O
no	O
IL-4	B-protein
-induced	O
Stat6	B-protein
phosphorylation	O
was	O
detected	O
in	O
E1C3	B-cell_line
cells	I-cell_line
.	O

IL-4	B-protein
also	O
induced	O
Stat6	B-protein
DNA	O
binding	O
activity	O
from	O
lysates	O
of	O
1D4	B-cell_line
but	O
not	O
E1C3	B-cell_line
cells	I-cell_line
utilizing	O
a	O
radiolabeled	B-DNA
immunoglobulin	I-DNA
heavy	I-DNA
chain	I-DNA
germline	I-DNA
epsilon	I-DNA
promotor	I-DNA
sequence	I-DNA
(	O
Iepsilon	B-DNA
)	O
in	O
an	O
electrophoretic	O
mobility	O
shift	O
assay	O
.	O

Reconstitution	O
of	O
Jak1	B-protein
expression	O
in	O
E1C3	B-cell_line
cells	I-cell_line
restored	O
the	O
ability	O
of	O
IL-4	B-protein
to	O
induce	O
IRS	B-DNA
and	O
Stat6	B-protein
tyrosine	O
phosphorylation	O
.	O

These	O
results	O
provide	O
evidence	O
that	O
Jak1	B-protein
expression	O
is	O
required	O
for	O
mediating	O
tyrosine	O
phosphorylation	O
and	O
activation	O
of	O
crucial	O
molecules	O
involved	O
in	O
IL-4	B-protein
signal	O
transduction	O
.	O

THE	NULL
JOURNAL	NULL
or	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
Vol	NULL
.	NULL

272	NULL
,	NULL
No	NULL
.	NULL

10	NULL
,	NULL
Issue	NULL
of	NULL
March	NULL
7	NULL
,	NULL
pp	NULL
.	NULL

6556-6560	NULL
,	NULL
1997	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Jak1	NULL
Expression	NULL
Is	NULL
Required	NULL
for	NULL
Mediating	NULL
Interleukin-4-induced	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
Insulin	NULL
Receptor	NULL
Substrate	NULL
and	NULL
Stat6	NULL
Signaling	NULL
Molecules*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
August	NULL
23	NULL
,	NULL
1996	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
December	NULL
20	NULL
,	NULL
1996	NULL
)	NULL
Xiao	NULL
Hong	NULL
Chen	NULL
#	NULL
§	NULL
,	NULL
Bharvin	NULL
K.	NULL
R.	NULL
Patel	NULL
#	NULL
§	NULL
,	NULL
Ling-Mei	NULL
Wang+	NULL
#	NULL
,	NULL
Mark	NULL
Frankel	NULL
}	NULL
,	NULL
Nelson	NULL
Ellmore	NULL
?	NULL

,	NULL
Richard	NULL
A.	NULL
Flavell1	NULL
,	NULL
William	NULL
J.	NULL
LaRochelle	NULL
#	NULL
,	NULL
and	NULL
Jacalyn	NULL
H.	NULL
Pierce	NULL
?	NULL

From	NULL
the	NULL
{	NULL
Laboratory	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
NCI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892-4255	NULL
and	NULL
\Section	NULL
of	NULL
Immunobiology	NULL
and	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
Yale	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
Connecticut	NULL
06510	NULL
The	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
and	NULL
Fes	NULL
tyrosine	NULL
kinases	NULL
have	NULL
been	NULL
demonstrated	NULL
to	NULL
undergo	NULL
tyrosine	NULL
phosphorylation	NULL
in	NULL
response	NULL
to	NULL
interleukin	NULL
(	NULL
IL	NULL
)	NULL
-4	NULL
stimulation	NULL
in	NULL
different	NULL
cell	NULL
systems	NULL
.	NULL

However	NULL
,	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
which	NULL
,	NULL
if	NULL
any	NULL
,	NULL
of	NULL
these	NULL
kinases	NULL
are	NULL
responsible	NULL
for	NULL
initiating	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
substrates	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
utilized	NULL
a	NULL
mutant	NULL
Jakl-deficient	NULL
HeLa	NULL
cell	NULL
line	NULL
,	NULL
E1C3	NULL
,	NULL
and	NULL
its	NULL
parental	NULL
Jakl-expressing	NULL
counterpart	NULL
,	NULL
1D4	NULL
,	NULL
to	NULL
analyze	NULL
the	NULL
role	NULL
of	NULL
Jakl	NULL
in	NULL
mediating	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
.	NULL

IL-4	NULL
treatment	NULL
rapidly	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
insulin	NULL
receptor	NULL
substrate	NULL
(	NULL
IRS	NULL
)	NULL
-1	NULL
and	NULL
IRS-2	NULL
in	NULL
1D4	NULL
but	NULL
not	NULL
in	NULL
E1C3	NULL
cells	NULL
.	NULL

IL-4-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat6	NULL
was	NULL
pronounced	NULL
in	NULL
1D4	NULL
cells	NULL
,	NULL
while	NULL
no	NULL
IL-4-induced	NULL
Stat6	NULL
phosphorylation	NULL
was	NULL
detected	NULL
in	NULL
E1C3	NULL
cells	NULL
.	NULL

IL-4	NULL
also	NULL
induced	NULL
Stat6	NULL
DNA	NULL
binding	NULL
activity	NULL
from	NULL
lysates	NULL
of	NULL
1D4	NULL
but	NULL
not	NULL
E1C3	NULL
cells	NULL
utilizing	NULL
a	NULL
radiolabeled	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
germline	NULL
e	NULL
promotor	NULL
sequence	NULL
(	NULL
Ie	NULL
)	NULL
in	NULL
an	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Reconstitution	NULL
of	NULL
Jak1	NULL
expression	NULL
in	NULL
E1C3	NULL
cells	NULL
restored	NULL
the	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
induce	NULL
IRS	NULL
and	NULL
Stat6	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
evidence	NULL
that	NULL
Jak1l	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
crucial	NULL
molecules	NULL
involved	NULL
in	NULL
IL-4	NULL
signal	NULL
transduction	NULL
.	NULL

Interleukin	NULL
(	NULL
IL	NULL
)	NULL
'-4	NULL
is	NULL
known	NULL
to	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
determining	NULL
the	NULL
nature	NULL
of	NULL
an	NULL
immune	NULL
response	NULL
to	NULL
a	NULL
given	NULL
pathogen	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-4	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
mediate	NULL
a	NULL
diverse	NULL
array	NULL
of	NULL
proliferative	NULL
and	NULL
functional	NULL
effects	NULL
in	NULL
cells	NULL
of	NULL
nonhematopoietic	NULL
origin	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
multifunctional	NULL
role	NULL
of	NULL
IL-4	NULL
is	NULL
reflected	NULL
by	NULL
the	NULL
ubiquitous	NULL
expression	NULL
of	NULL
IL-4	NULL
receptors	NULL
(	NULL
IL-4Rs	NULL
)	NULL
in	NULL
both	NULL
hematopoietic	NULL
and	NULL
nonhematopoietic	NULL
cell	NULL
types	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
encoding	NULL
a	NULL
high	NULL
affinity	NULL
subunit	NULL
for	NULL
the	NULL
human	NULL
IL-4R	NULL
has	NULL
been	NULL
cloned	NULL
and	NULL
termed	NULL
IL-4Ra	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
*	NULL
The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
addressed	NULL
:	NULL
Laboratory	NULL
of	NULL
Cellular	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
NCI	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Bldg	NULL
.	NULL

37	NULL
,	NULL
Rm	NULL
.	NULL

1624	NULL
,	NULL
37	NULL
Convent	NULL
Drive-MSC	NULL
4255	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-4255	NULL
;	NULL
Tel	NULL
.	NULL

:	NULL
301-496-8911	NULL
;	NULL
Fax	NULL
:	NULL
801-496-8479	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
IL	NULL
,	NULL
interleukin	NULL
;	NULL
IL-2R	NULL
and	NULL
IL-4R	NULL
,	NULL
IL-2	NULL
and	NULL
IL-4	NULL
receptor	NULL
;	NULL
IRS	NULL
,	NULL
insulin	NULL
receptor	NULL
substrate	NULL
;	NULL
mAb	NULL
,	NULL
monoclonal	NULL
antibody	NULL
;	NULL
PE	NULL
,	NULL
phycoerythrin	NULL
;	NULL
PBS	NULL
,	NULL
phosphate-buffered	NULL
saline	NULL
;	NULL
PAGE	NULL
,	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
;	NULL
BSA	NULL
,	NULL
bovine	NULL
serum	NULL
albumin	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

6556	NULL
IL-4Ra	NULL
sequence	NULL
revealed	NULL
that	NULL
it	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
hemato-poietin	NULL
receptor	NULL
superfamily	NULL
.	NULL

While	NULL
IL-4Ra	NULL
possesses	NULL
a	NULL
large	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
approximately	NULL
500	NULL
amino	NULL
acids	NULL
,	NULL
no	NULL
consensus	NULL
sequences	NULL
for	NULL
tyrosine	NULL
or	NULL
serine/threonine	NULL
kinases	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
can	NULL
also	NULL
utilize	NULL
the	NULL
y	NULL
chain	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
(	NULL
IL-2Ry	NULL
)	NULL
in	NULL
a	NULL
complex	NULL
with	NULL
IL-4Ra	NULL
to	NULL
enhance	NULL
ligand	NULL
binding	NULL
and	NULL
signal	NULL
transduction	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
.	NULL

Despite	NULL
the	NULL
lack	NULL
of	NULL
a	NULL
tyrosine	NULL
kinase	NULL
domain	NULL
in	NULL
the	NULL
cytoplasmic	NULL
region	NULL
of	NULL
either	NULL
IL-4Ra	NULL
or	NULL
IL-2Ry	NULL
,	NULL
IL-4	NULL
stimulation	NULL
leads	NULL
to	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IL-4Ra	NULL
«	NULL
and	NULL
certain	NULL
intracellular	NULL
signaling	NULL
molecules	NULL
.	NULL

IL-4	NULL
treatment	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
result	NULL
in	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
insulin	NULL
receptor	NULL
sub-strate-1	NULL
(	NULL
IRS-1	NULL
)	NULL
,	NULL
IRS-2	NULL
(	NULL
formerly	NULL
termed	NULL
4PS	NULL
)	NULL
,	NULL
Stat6	NULL
,	NULL
and	NULL
other	NULL
undefined	NULL
molecules	NULL
(	NULL
9-16	NULL
)	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
established	NULL
that	NULL
expression	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
or	NULL
IRS-2	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
IL-4-mediated	NULL
mitogenesis	NULL
in	NULL
32D	NULL
myeloid	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
characterizing	NULL
the	NULL
phenotype	NULL
of	NULL
Stat6	NULL
'~	NULL
mice	NULL
have	NULL
provided	NULL
evidence	NULL
that	NULL
Stat6	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
multiple	NULL
functional	NULL
responses	NULL
induced	NULL
by	NULL
IL-4	NULL
and	NULL
strongly	NULL
implicate	NULL
Stat6	NULL
involvement	NULL
in	NULL
IL-4-induced	NULL
proliferative	NULL
effects	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

It	NULL
is	NULL
well	NULL
established	NULL
that	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
is	NULL
essential	NULL
for	NULL
their	NULL
dimerization	NULL
and	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
activate	NULL
transcription	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
substantiate	NULL
that	NULL
tyrosine	NULL
kinase-mediated	NULL
phosphorylation	NULL
events	NULL
play	NULL
an	NULL
integral	NULL
role	NULL
in	NULL
implementing	NULL
IL-4	NULL
signal	NULL
transduction	NULL
.	NULL

Three	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
kinase	NULL
family	NULL
,	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
and	NULL
Jak3	NULL
,	NULL
and	NULL
the	NULL
Fes	NULL
proto-oncogene	NULL
product	NULL
are	NULL
the	NULL
only	NULL
tyrosine	NULL
kinases	NULL
that	NULL
have	NULL
been	NULL
reported	NULL
to	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
and/or	NULL
activated	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
stimulation	NULL
in	NULL
different	NULL
cell	NULL
systems	NULL
(	NULL
24-28	NULL
)	NULL
.	NULL

While	NULL
IL-4-mediated	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
Jak1	NULL
,	NULL
Jak3	NULL
,	NULL
and	NULL
Fes	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
many	NULL
cell	NULL
systems	NULL
(	NULL
24-27	NULL
)	NULL
,	NULL
phosphorylation	NULL
of	NULL
Jak2	NULL
has	NULL
only	NULL
been	NULL
reported	NULL
to	NULL
occur	NULL
in	NULL
human	NULL
colon	NULL
carcinoma	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
stimulation	NULL
induces	NULL
Jak1	NULL
and	NULL
Fes	NULL
association	NULL
with	NULL
IL-4Ra	NULL
,	NULL
while	NULL
Jak3	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
interact	NULL
with	NULL
IL-2Ry	NULL
(	NULL
24-27	NULL
)	NULL
.	NULL

Cotransfection	NULL
studies	NULL
in	NULL
COS	NULL
cells	NULL
and	NULL
in	NULL
vitro	NULL
experiments	NULL
have	NULL
indicated	NULL
that	NULL
both	NULL
Jak1	NULL
and	NULL
Jak3	NULL
are	NULL
able	NULL
to	NULL
associate	NULL
with	NULL
and	NULL
mediate	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
.	NULL

However	NULL
,	NULL
it	NULL
has	NULL
not	NULL
been	NULL
determined	NULL
which	NULL
,	NULL
if	NULL
any	NULL
,	NULL
of	NULL
these	NULL
kinases	NULL
are	NULL
involved	NULL
in	NULL
mediating	NULL
IL-4-induced	NULL
phosphorylation	NULL
of	NULL
downstream	NULL
signaling	NULL
substrates	NULL
under	NULL
physiological	NULL
conditions	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
have	NULL
utilized	NULL
a	NULL
mutant	NULL
HeLa	NULL
cell	NULL
line	NULL
,	NULL
originally	NULL
isolated	NULL
based	NULL
on	NULL
its	NULL
lack	NULL
of	NULL
interferon	NULL
responsive-ness	NULL
,	NULL
that	NULL
is	NULL
deficient	NULL
in	NULL
Jakl	NULL
expression	NULL
and	NULL
its	NULL
parental	NULL
counterpart	NULL
that	NULL
does	NULL
express	NULL
Jak1	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
to	NULL
determine	NULL
if	NULL
this	NULL
This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www-jbc.stanford.edu/jbc/	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Jak1	NULL
Requirement	NULL
for	NULL
IL-4	NULL
Signal	NULL
Transduction	NULL
tyrosine	NULL
kinase	NULL
is	NULL
responsible	NULL
for	NULL
mediating	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
in	NULL
vivo	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Materials-The	NULL
1D4	NULL
and	NULL
E1C3	NULL
Hela	NULL
cell	NULL
lines	NULL
have	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
,	NULL
32	NULL
)	NULL
.	NULL

The	NULL
human	NULL
T	NULL
lymphoid	NULL
Jurkat	NULL
cell	NULL
line	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
L.	NULL
Samelson	NULL
,	NULL
and	NULL
the	NULL
human	NULL
monocytic	NULL
U987	NULL
and	NULL
B	NULL
lymphoid	NULL
Ramos	NULL
cell	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
ATCC	NULL
.	NULL

Human	NULL
recombinant	NULL
IL-4	NULL
was	NULL
obtained	NULL
from	NULL
Peprotech	NULL
and	NULL
insulin	NULL
was	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
Murine	NULL
anti-Jakl	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Signal	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
anti-phosphotyrosine	NULL
mAb	NULL
,	NULL
anti-Jak2	NULL
,	NULL
and	NULL
anti-Jak3	NULL
sera	NULL
were	NULL
from	NULL
Upstate	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
,	NULL
and	NULL
anti-Fes	NULL
mAb	NULL
was	NULL
from	NULL
Oncogene	NULL
Sciences	NULL
.	NULL

The	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
-conjugated	NULL
IL-4	NULL
fluorokine	NULL
receptor	NULL
reagent	NULL
kit	NULL
was	NULL
obtained	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
.	NULL

Rabbit	NULL
anti-IRS-1	NULL
and	NULL
anti-IRS-2	NULL
sera	NULL
were	NULL
generated	NULL
by	NULL
immunization	NULL
of	NULL
rabbits	NULL
with	NULL
baculovirus-ex-pressed	NULL
rat	NULL
IRS-1	NULL
protein	NULL
or	NULL
an	NULL
IRS-2-specific	NULL
peptide	NULL
comprised	NULL
of	NULL
amino	NULL
acid	NULL
residues	NULL
1810	NULL
to	NULL
1822	NULL
(	NULL
LSHHLKEATVVKE	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
anti-IRS-1	NULL
serum	NULL
very	NULL
weakly	NULL
recognizes	NULL
IRS-2	NULL
,	NULL
while	NULL
anti-IRS-2	NULL
serum	NULL
does	NULL
not	NULL
recognize	NULL
IRS-1	NULL
.	NULL

The	NULL
anti-Stat6	NULL
peptide	NULL
serum	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
and	NULL
immunoblot	NULL
analysis	NULL
was	NULL
raised	NULL
against	NULL
amino	NULL
acid	NULL
residues	NULL
787-804	NULL
(	NULL
GEDIFPPLLPPTEQDLTK	NULL
)	NULL
of	NULL
human	NULL
Stat6	NULL
.	NULL

Flow	NULL
Cytometry-The	NULL
adherent	NULL
1D4	NULL
and	NULL
E1C3	NULL
HeLa	NULL
cell	NULL
lines	NULL
were	NULL
treated	NULL
with	NULL
0.5	NULL
mM	NULL
EDTA	NULL
to	NULL
facilitate	NULL
their	NULL
removal	NULL
from	NULL
the	NULL
sub-strate	NULL
.	NULL

Helia	NULL
and	NULL
Ramos	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
and	NULL
resuspended	NULL
at	NULL
5	NULL
X	NULL
10°	NULL
cells/ml	NULL
.	NULL

PE-conjugated	NULL
IL-4	NULL
(	NULL
10	NULL
ul	NULL
)	NULL
was	NULL
added	NULL
to	NULL
25	NULL
pl	NULL
of	NULL
washed	NULL
cells	NULL
.	NULL

As	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
20	NULL
ul	NULL
of	NULL
anti-human	NULL
IL-4	NULL
neutralizing	NULL
antibody	NULL
was	NULL
mixed	NULL
with	NULL
10	NULL
ul	NULL
of	NULL
PE-conjugated	NULL
IL-4	NULL
and	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
before	NULL
addition	NULL
to	NULL
the	NULL
cell	NULL
suspensions	NULL
.	NULL

Samples	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
at	NULL
16	NULL
°C	NULL
and	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
containing	NULL
0.1	NULL
%	NULL
NaN	NULL
,	NULL
.	NULL

Flow	NULL
cytometry	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
FACScan	NULL
(	NULL
Becton-Dickenson	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Immunoblot	NULL
Analysis-Hela	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
and	NULL
starved	NULL
for	NULL
4	NULL
h	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
5	NULL
ug/ml	NULL
transferrin	NULL
and	NULL
10	NULL
nM	NULL
selenium	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
IL-4	NULL
or	NULL
insulin	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
for	NULL
10	NULL
min	NULL
at	NULL
87	NULL
°C	NULL
,	NULL
cells	NULL
were	NULL
diluted	NULL
in	NULL
PBS	NULL
containing	NULL
100	NULL
pM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
then	NULL
lysed	NULL
in	NULL
buffer	NULL
containing	NULL
50	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mM	NULL
NaPP	NULL
,	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
phenylmethy	NULL
]	NULL
-sulfonyl	NULL
fluoride	NULL
,	NULL
10	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
10	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
10	NULL
ug/ml	NULL
pepstatin	NULL
.	NULL

The	NULL
total	NULL
protein	NULL
content	NULL
of	NULL
the	NULL
lysates	NULL
was	NULL
determined	NULL
by	NULL
the	NULL
Bio-Rad	NULL
protein	NULL
assay	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
clarified	NULL
cell	NULL
lysates	NULL
(	NULL
0.5-1	NULL
mg	NULL
)	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
different	NULL
antisera	NULL
(	NULL
1:500	NULL
)	NULL
plus	NULL
80	NULL
ul	NULL
of	NULL
protein	NULL
G-coupled	NULL
Sepharose	NULL
(	NULL
Pharmacia	NULL
Biotech	NULL
Inc.	NULL
)	NULL
.	NULL

Immunopre-cipitates	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
,	NULL
solubilized	NULL
with	NULL
Laemmli	NULL
buffer	NULL
,	NULL
boiled	NULL
,	NULL
and	NULL
resolved	NULL
by	NULL
8	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
.	NULL

For	NULL
direct	NULL
immunoblot	NULL
analysis	NULL
,	NULL
proteins	NULL
from	NULL
lysates	NULL
of	NULL
the	NULL
various	NULL
cell	NULL
lines	NULL
(	NULL
200	NULL
ug	NULL
)	NULL
were	NULL
directly	NULL
resolved	NULL
by	NULL
SDS-PAGE	NULL
without	NULL
prior	NULL
serum	NULL
starvation	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
transferring	NULL
separated	NULL
proteins	NULL
onto	NULL
a	NULL
polyvinylidene	NULL
difluoride	NULL
membrane	NULL
(	NULL
Immo-bilon-P	NULL
;	NULL
Millipore	NULL
)	NULL
in	NULL
Tris-glyceride	NULL
buffer	NULL
containing	NULL
20	NULL
%	NULL
methanol	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
treated	NULL
for	NULL
1-2	NULL
h	NULL
with	NULL
8	NULL
%	NULL
non-fat	NULL
dry	NULL
milk	NULL
in	NULL
TTBS	NULL
(	NULL
20	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
154	NULL
mM	NULL
NaCl	NULL
,	NULL
0.05	NULL
%	NULL
Tween	NULL
,	NULL
0.05	NULL
%	NULL
NaN	NULL
,	NULL
,	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
antibodies	NULL
in	NULL
TTBS	NULL
containing	NULL
0.5	NULL
%	NULL
BSA	NULL
(	NULL
TTBS-BSA	NULL
)	NULL
for	NULL
1	NULL
to	NULL
2	NULL
h	NULL
(	NULL
concentration	NULL
of	NULL
antibodies	NULL
:	NULL
2	NULL
ug/ml	NULL
for	NULL
anti-Tyr	NULL
(	NULL
P	NULL
)	NULL
and	NULL
1:500	NULL
for	NULL
the	NULL
remaining	NULL
antisera	NULL
)	NULL
and	NULL
reacted	NULL
with	NULL
'*	NULL
``	NULL
T-labeled	NULL
protein	NULL
A	NULL
(	NULL
3	NULL
X	NULL
10°	NULL
cpm/ul	NULL
)	NULL
in	NULL
TTBS-BSA	NULL
for	NULL
1	NULL
h.	NULL
Alternatively	NULL
,	NULL
bound	NULL
antibody	NULL
was	NULL
detected	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
protocol	NULL
(	NULL
Amersham	NULL
Corp.	NULL
)	NULL
.	NULL

All	NULL
procedures	NULL
were	NULL
done	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
and	NULL
membranes	NULL
were	NULL
washed	NULL
extensively	NULL
with	NULL
TTBS	NULL
after	NULL
each	NULL
treatment	NULL
.	NULL

After	NULL
the	NULL
final	NULL
wash	NULL
,	NULL
the	NULL
membrane	NULL
was	NULL
rinsed	NULL
with	NULL
distilled	NULL
water	NULL
,	NULL
air	NULL
dried	NULL
and	NULL
autoradiographed	NULL
with	NULL
an	NULL
intensifying	NULL
screen	NULL
at	NULL
-70	NULL
°C	NULL
.	NULL

Electrophorectic	NULL
Mobility	NULL
Shift	NULL
Assay-DNA	NULL
oligonucleotide	NULL
probes	NULL
used	NULL
in	NULL
the	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
were	NULL
annealed	NULL
,	NULL
labeled	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
for	NULL
EMSA	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
14-16	NULL
,	NULL
38	NULL
)	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
one	NULL
strand	NULL
of	NULL
the	NULL
double-stranded	NULL
Ie	NULL
probe	NULL
used	NULL
for	NULL
EMSA	NULL
was	NULL
5'-GATCTA-ACTTCCCAAGAACAG-3	NULL
'	NULL
.	NULL

Briefly	NULL
,	NULL
1D4	NULL
and	NULL
E1C3	NULL
cells	NULL
were	NULL
serum-starved	NULL
overnight	NULL
and	NULL
treated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
IL-4	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
PBS	NULL
containing	NULL
100	NULL
uM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
and	NULL
solubilized	NULL
in	NULL
gel	NULL
shift	NULL
lysis	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-Cl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
100	NULL
um	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
167	NULL
mM	NULL
NaCl	NULL
,	NULL
100	NULL
uM	NULL
Na	NULL
,	NULL
VO	NULL
,	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
400	NULL
uM	NULL
dimethyl	NULL
sulfoxide	NULL
,	NULL
1	NULL
ug/ml	NULL
aprotinin	NULL
,	NULL
1	NULL
ug/ml	NULL
leupeptin	NULL
,	NULL
and	NULL
1	NULL
ug/ml	NULL
pepstatin	NULL
)	NULL
by	NULL
incubation	NULL
on	NULL
ice	NULL
for	NULL
1	NULL
h	NULL
and	NULL
6557	NULL
A	NULL
Jurkat	NULL
1D4	NULL
E1C3	NULL
1D4	NULL
E1C3	NULL
Jurkat	NULL
Jurkat	NULL
1D4	NULL
E1C3	NULL
u937	NULL
1D4	NULL
E1C3	NULL
wil	NULL
-	NULL
]	NULL
~	NULL
es	NULL
97	NULL
-	NULL
|	NULL
I	NULL
Ta	NULL
<	NULL
Fes	NULL
Blot	NULL
:	NULL
anti-	NULL
anti-	NULL
-	NULL
anti-	NULL
anti-Jaki	NULL
Jak2	NULL
-	NULL
Jak3	NULL
Fes	NULL
Relative	NULL
Cell	NULL
Number	NULL
us	NULL
Fluorescence	NULL
Intensity	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Analysis	NULL
of	NULL
1D4	NULL
and	NULL
EIC3	NULL
cells	NULL
for	NULL
Jak1	NULL
,	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
Fes	NULL
and	NULL
expression	NULL
,	NULL
and	NULL
the	NULL
ability	NULL
to	NULL
bind	NULL
human	NULL
IL-4	NULL
.	NULL

A	NULL
,	NULL
equivalent	NULL
amounts	NULL
of	NULL
proteins	NULL
from	NULL
lysates	NULL
of	NULL
Jurkat	NULL
,	NULL
U987	NULL
,	NULL
1D4	NULL
,	NULL
or	NULL
E1C3	NULL
cells	NULL
were	NULL
immunoblotted	NULL
(	NULL
Blot	NULL
)	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
Jak1l	NULL
,	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
or	NULL
Fes	NULL
,	NULL
as	NULL
designated	NULL
.	NULL

The	NULL
molecular	NULL
mass	NULL
marker	NULL
is	NULL
shown	NULL
in	NULL
kilodaltons	NULL
,	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
the	NULL
various	NULL
kinases	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

B	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
PE-conjugated	NULL
human	NULL
IL-4	NULL
to	NULL
bind	NULL
to	NULL
1D4	NULL
,	NULL
E1C3	NULL
,	NULL
or	NULL
Ramos	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
solid	NULL
line	NULL
histogram	NULL
represents	NULL
cells	NULL
treated	NULL
with	NULL
PE-conjugated	NULL
IL-4	NULL
,	NULL
and	NULL
the	NULL
doffed	NULL
line	NULL
histogram	NULL
represents	NULL
cells	NULL
treated	NULL
with	NULL
PE-conjugated	NULL
IL-4	NULL
incubated	NULL
with	NULL
anti-IL-4	NULL
neutralizing	NULL
antibody	NULL
.	NULL

vortexing	NULL
three	NULL
to	NULL
five	NULL
times	NULL
.	NULL

Lysates	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
at	NULL
14,000	NULL
rpm	NULL
for	NULL
10	NULL
min	NULL
,	NULL
and	NULL
protein	NULL
concentrations	NULL
were	NULL
determined	NULL
.	NULL

For	NULL
EMSA	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
whole	NULL
cell	NULL
lysate	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
*°P-labeled	NULL
Ie	NULL
probe	NULL
in	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
40	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
mm	NULL
MgCl	NULL
,	NULL
,	NULL
100	NULL
uM	NULL
EDTA	NULL
,	NULL
500	NULL
uM	NULL
dithiothreitol	NULL
,	NULL
6.0	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mg/ml	NULL
BSA	NULL
,	NULL
and	NULL
100	NULL
ug/ml	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Complexes	NULL
were	NULL
subsequently	NULL
fraction-ated	NULL
on	NULL
0.22	NULL
X	NULL
TBE	NULL
(	NULL
100	NULL
mM	NULL
Tris	NULL
borate	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
EDTA	NULL
)	NULL
4.5	NULL
%	NULL
acrylamide	NULL
gels	NULL
.	NULL

Transient	NULL
Transfection	NULL
Assay-E1C3	NULL
cells	NULL
(	NULL
4	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
plated	NULL
in	NULL
a	NULL
10-mm	NULL
tissue	NULL
culture	NULL
dish	NULL
24	NULL
h	NULL
before	NULL
transfection	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
a	NULL
retroviral	NULL
expression	NULL
vector	NULL
containing	NULL
murine	NULL
JAK1	NULL
cDNA	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Dr.	NULL
Warren	NULL
Leonard	NULL
)	NULL
and	NULL
40	NULL
ug	NULL
of	NULL
carrier	NULL
DNA	NULL
using	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
.	NULL

Eighteen	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
incubated	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
for	NULL
7-12	NULL
h.	NULL
Cells	NULL
were	NULL
then	NULL
serum-starved	NULL
as	NULL
described	NULL
previously	NULL
and	NULL
used	NULL
for	NULL
subsequent	NULL
experiments	NULL
.	NULL

RESULTS	NULL
AND	NULL
DISCUSSION	NULL
To	NULL
confirm	NULL
that	NULL
parental	NULL
1D4	NULL
HeLa	NULL
cells	NULL
expressed	NULL
Jak1	NULL
and	NULL
that	NULL
mutant	NULL
EIC3	NULL
Hela	NULL
cells	NULL
were	NULL
Jak1l-deficient	NULL
,	NULL
whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
and	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
utilizing	NULL
an	NULL
anti-Jakl	NULL
mAb	NULL
.	NULL

A	NULL
130-kDa	NULL
protein	NULL
was	NULL
readily	NULL
expressed	NULL
in	NULL
1D4	NULL
cells	NULL
,	NULL
while	NULL
no	NULL
protein	NULL
in	NULL
this	NULL
size	NULL
range	NULL
was	NULL
observed	NULL
in	NULL
EIC3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
130-kDa	NULL
protein	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
Jurkat	NULL
cells	NULL
that	NULL
are	NULL
known	NULL
to	NULL
express	NULL
Jak1	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

The	NULL
status	NULL
of	NULL
Jak2	NULL
,	NULL
Jak3	NULL
,	NULL
and	NULL
Fes	NULL
expression	NULL
in	NULL
the	NULL
two	NULL
Hela	NULL
cell	NULL
lines	NULL
was	NULL
also	NULL
examined	NULL
by	NULL
immunoblot	NULL
analysis	NULL
,	NULL
since	NULL
these	NULL
tyrosine	NULL
kinases	NULL
have	NULL
also	NULL
been	NULL
demonstrated	NULL
to	NULL
become	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
treatment	NULL
(	NULL
24	NULL
,	NULL
25	NULL
,	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Anti-Jak2	NULL
serum	NULL
recognized	NULL
a	NULL
130-kDa	NULL
protein	NULL
in	NULL
Jurkat	NULL
,	NULL
1D4	NULL
,	NULL
and	NULL
EIC3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

A	NULL
Jak2	NULL
degradation	NULL
product	NULL
of	NULL
97	NULL
kDa	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
all	NULL
three	NULL
lines	NULL
.	NULL

Anti-Jak3	NULL
serum	NULL
specifically	NULL
detected	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
120-kDa	NULL
protein	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
while	NULL
no	NULL
protein	NULL
in	NULL
this	NULL
size	NULL
range	NULL
was	NULL
observed	NULL
in	NULL
either	NULL
1D4	NULL
or	NULL
E1C3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

A	NULL
92-kDa	NULL
protein	NULL
was	NULL
detected	NULL
in	NULL
human	NULL
U937	NULL
myeloid	NULL
cells	NULL
that	NULL
are	NULL
known	NULL
to	NULL
express	NULL
Fes	NULL
but	NULL
not	NULL
in	NULL
1D4	NULL
or	NULL
E1C3	NULL
cells	NULL
utilizing	NULL
an	NULL
anti-Fes	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
mutant	NULL
EIC3	NULL
cells	NULL
do	NULL
not	NULL
detectably	NULL
express	NULL
Jak1	NULL
,	NULL
Jak3	NULL
,	NULL
or	NULL
Fes	NULL
but	NULL
do	NULL
express	NULL
Jak2	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
6558	NULL
A	NULL
104	NULL
E10C3	NULL
T	NULL
w	NULL
a	NULL
:	NULL
2	NULL
od	NULL
2	NULL
200-	NULL
IP	NULL
:	NULL
anti-lRS-1	NULL
IRS-1	NULL
>	NULL
-	NULL
.	NULL

.	NULL

Blot	NULL
:	NULL
anti-PY	NULL
B	NULL
200	NULL
IP	NULL
:	NULL
anti-lRS-2	NULL
ins	NULL
»	NULL
wei	NULL
U	NULL
_	NULL
Biot	NULL
:	NULL
anti-PY	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

IL-4	NULL
mediates	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
in	NULL
1D4	NULL
but	NULL
not	NULL
in	NULL
E1C3	NULL
cells	NULL
.	NULL

1D4	NULL
or	NULL
E1C3	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-4	NULL
or	NULL
insulin	NULL
(	NULL
INS	NULL
)	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
ZP	NULL
)	NULL
with	NULL
A	NULL
,	NULL
anti-IRS-1	NULL
or	NULL
B	NULL
,	NULL
anti-IRS-2	NULL
serum	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
proteins	NULL
were	NULL
immunoblotted	NULL
(	NULL
Blot	NULL
)	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
anti-PY	NULL
)	NULL
,	NULL
as	NULL
designated	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
shown	NULL
in	NULL
kilodaltons	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

IL-4Rs	NULL
have	NULL
been	NULL
detected	NULL
on	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
hematopoietic	NULL
and	NULL
nonhematopoietic	NULL
cell	NULL
types	NULL
at	NULL
levels	NULL
ranging	NULL
from	NULL
100	NULL
to	NULL
5000	NULL
sites	NULL
per	NULL
cell	NULL
(	NULL
2-4	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
compare	NULL
IL-4-induced	NULL
signal	NULL
transduction	NULL
events	NULL
in	NULL
the	NULL
1D4	NULL
and	NULL
E1C3	NULL
cell	NULL
lines	NULL
,	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
determine	NULL
whether	NULL
these	NULL
lines	NULL
expressed	NULL
receptors	NULL
capable	NULL
of	NULL
binding	NULL
IL-4	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
1D4	NULL
and	NULL
E1C3	NULL
cells	NULL
specifically	NULL
bound	NULL
PE-conjugated	NULL
human	NULL
IL-4	NULL
.	NULL

The	NULL
human	NULL
B	NULL
Ramos	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
is	NULL
known	NULL
to	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
IL-4Rs	NULL
(	NULL
2	NULL
)	NULL
,	NULL
was	NULL
also	NULL
found	NULL
to	NULL
specifically	NULL
bind	NULL
PE-conjugated	NULL
human	NULL
IL-4	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
mutant	NULL
E1C3	NULL
cells	NULL
and	NULL
their	NULL
1D4	NULL
parental	NULL
counterpart	NULL
express	NULL
detectable	NULL
levels	NULL
of	NULL
cell	NULL
surface	NULL
IL-4Rs	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
in	NULL
1D4	NULL
and	NULL
E1C3	NULL
was	NULL
next	NULL
examined	NULL
.	NULL

Cells	NULL
were	NULL
serum	NULL
starved	NULL
and	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
IL-4	NULL
or	NULL
insulin	NULL
.	NULL

Insulin	NULL
treatment	NULL
was	NULL
performed	NULL
because	NULL
it	NULL
is	NULL
known	NULL
to	NULL
mediate	NULL
potent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS	NULL
mol-ecules	NULL
,	NULL
and	NULL
evidence	NULL
suggests	NULL
that	NULL
activated	NULL
insulin	NULL
receptors	NULL
directly	NULL
associate	NULL
with	NULL
and	NULL
phosphorylate	NULL
these	NULL
substrates	NULL
(	NULL
34-36	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
either	NULL
IRS-1	NULL
or	NULL
IRS-2	NULL
and	NULL
subsequently	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
utilizing	NULL
anti-phosphotyrosine	NULL
.	NULL

IL-4	NULL
treatment	NULL
of	NULL
1D4	NULL
cells	NULL
resulted	NULL
in	NULL
pronounced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
,	NULL
while	NULL
no	NULL
detectable	NULL
phosphorylation	NULL
of	NULL
either	NULL
substrate	NULL
was	NULL
observed	NULL
in	NULL
E1C3	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
and	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
insulin	NULL
treatment	NULL
led	NULL
to	NULL
equivalent	NULL
increases	NULL
in	NULL
the	NULL
phosphotyrosine	NULL
content	NULL
of	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
molecules	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
the	NULL
same	NULL
samples	NULL
with	NULL
either	NULL
anti-IRS-1	NULL
or	NULL
anti-IRS-2	NULL
serum	NULL
revealed	NULL
that	NULL
equivalent	NULL
amounts	NULL
of	NULL
IRS	NULL
proteins	NULL
were	NULL
present	NULL
in	NULL
each	NULL
immunoprecipitate	NULL
and	NULL
that	NULL
IRS	NULL
expression	NULL
was	NULL
similar	NULL
in	NULL
both	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
IL-4-induced	NULL
IRS-1	NULL
and	NULL
IRS-2	NULL
phosphorylation	NULL
is	NULL
mediated	NULL
through	NULL
activation	NULL
of	NULL
Jak1	NULL
,	NULL
while	NULL
insulin-induced	NULL
IRS	NULL
phosphorylation	NULL
does	NULL
not	NULL
require	NULL
Jak1	NULL
expression	NULL
.	NULL

It	NULL
has	NULL
been	NULL
established	NULL
that	NULL
IL-4	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat6	NULL
and	NULL
binding	NULL
of	NULL
Stat6	NULL
to	NULL
a	NULL
specific	NULL
DNA	NULL
consensus	NULL
sequence	NULL
,	NULL
TTCC	NULL
(	NULL
A	NULL
>	NULL
T	NULL
,	NULL
N	NULL
)	NULL
GGAA	NULL
(	NULL
13-16	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
if	NULL
Jakl	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
these	NULL
events	NULL
,	NULL
we	NULL
first	NULL
analyzed	NULL
whether	NULL
IL-4	NULL
could	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
Stat6	NULL
in	NULL
the	NULL
two	NULL
HeLa	NULL
cell	NULL
lines	NULL
.	NULL

Lysates	NULL
prepared	NULL
from	NULL
untreated	NULL
or	NULL
IL-4-stimulated	NULL
cells	NULL
were	NULL
immunoprecipitated	NULL
2	NULL
X.	NULL
H.	NULL
Chen	NULL
and	NULL
L.-M.	NULL
Wang	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

Jak1	NULL
Requirement	NULL
for	NULL
IL-4	NULL
Signal	NULL
Transduction	NULL
A	NULL
1D4	NULL
_	NULL
E1C3	NULL
%	NULL
%	NULL
o	NULL
<	NULL
o	NULL
@	NULL
IP	NULL
:	NULL
-	NULL
anti-Stat6	NULL
Staté	NULL
»	NULL
camn	NULL
Blot	NULL
:	NULL
anti-PY	NULL
97	NULL
B	NULL
-	NULL
.	NULL

IP	NULL
:	NULL
-	NULL
anti-Stat6	NULL
51mg	NULL
;	NULL
mas	NULL
aus	NULL
#	NULL
>	NULL
_	NULL
giot	NULL
:	NULL
anti-Staté	NULL
1D4	NULL
E1C3	NULL
*	NULL
¥	NULL
o	NULL
id	NULL
o	NULL
@	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

IL-4	NULL
induces	NULL
Stat6	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
in	NULL
1D4	NULL
but	NULL
not	NULL
in	NULL
E1C3	NULL
cells	NULL
.	NULL

1D4	NULL
or	NULL
E1C3	NULL
cells	NULL
were	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
IL-4	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
anti-Stat6	NULL
serum	NULL
and	NULL
subsequently	NULL
immunoblotted	NULL
(	NULL
Blof	NULL
)	NULL
with	NULL
A	NULL
,	NULL
anti-phosphotyrosine	NULL
(	NULL
anti-PY	NULL
)	NULL
or	NULL
B	NULL
,	NULL
anti-Stat6	NULL
serum	NULL
.	NULL

Molecular	NULL
mass	NULL
markers	NULL
are	NULL
shown	NULL
in	NULL
kilodaltons	NULL
,	NULL
and	NULL
the	NULL
positions	NULL
of	NULL
Stat6	NULL
are	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

C	NULL
,	NULL
whole	NULL
cell	NULL
lysates	NULL
from	NULL
untreated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
IL-4-stimulated	NULL
1D4	NULL
or	NULL
E1C3	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
*°P-labeled	NULL
Ie	NULL
for	NULL
10	NULL
min	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
as	NULL
indicated	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

The	NULL
position	NULL
of	NULL
the	NULL
IL-4-induced	NULL
Ie	NULL
mobility	NULL
shift	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrowhead	NULL
.	NULL

with	NULL
antiserum	NULL
specific	NULL
for	NULL
human	NULL
Stat6	NULL
,	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
transferred	NULL
proteins	NULL
were	NULL
subjected	NULL
to	NULL
immunoblot	NULL
analysis	NULL
utilizing	NULL
anti-phosphotyrosine	NULL
.	NULL

While	NULL
IL-4	NULL
stimulation	NULL
of	NULL
1D4	NULL
cells	NULL
resulted	NULL
in	NULL
evident	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
100-kDa	NULL
protein	NULL
specifically	NULL
recognized	NULL
by	NULL
anti-Stat6	NULL
serum	NULL
,	NULL
no	NULL
tyrosine-phosphorylated	NULL
protein	NULL
in	NULL
this	NULL
size	NULL
range	NULL
was	NULL
detected	NULL
in	NULL
response	NULL
to	NULL
IL-4	NULL
treatment	NULL
of	NULL
E1C3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
the	NULL
same	NULL
immunoprecipitated	NULL
lysates	NULL
with	NULL
anti-Stat6	NULL
serum	NULL
demonstrated	NULL
that	NULL
Stat6	NULL
expression	NULL
levels	NULL
were	NULL
comparable	NULL
in	NULL
the	NULL
1D4	NULL
and	NULL
E1C3	NULL
cell	NULL
lines	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Stat6	NULL
can	NULL
be	NULL
distinguished	NULL
from	NULL
other	NULL
Stat	NULL
proteins	NULL
by	NULL
its	NULL
ability	NULL
to	NULL
bind	NULL
to	NULL
a	NULL
specific	NULL
consensus	NULL
sequence	NULL
found	NULL
in	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
germ	NULL
line	NULL
promotor	NULL
of	NULL
the	NULL
IL-4-responsive	NULL
human	NULL
Ce	NULL
gene	NULL
,	NULL
designated	NULL
Ie	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
IL-4	NULL
could	NULL
induce	NULL
Stat6	NULL
binding	NULL
activity	NULL
in	NULL
1D4	NULL
and	NULL
E1C3	NULL
cells	NULL
,	NULL
whole	NULL
cell	NULL
extracts	NULL
from	NULL
untreated	NULL
or	NULL
IL-4-treated	NULL
cells	NULL
were	NULL
prepared	NULL
and	NULL
assayed	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
°°P-labeled	NULL
Ie	NULL
DNA	NULL
binding	NULL
activity	NULL
by	NULL
EMSA	NULL
.	NULL

IL-4	NULL
stimulation	NULL
of	NULL
1D4	NULL
cells	NULL
led	NULL
to	NULL
rapid	NULL
induction	NULL
of	NULL
Ie	NULL
binding	NULL
,	NULL
while	NULL
no	NULL
detectable	NULL
binding	NULL
activity	NULL
could	NULL
be	NULL
observed	NULL
after	NULL
IL-4	NULL
treatment	NULL
of	NULL
E1C3	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Jakl	NULL
expression	NULL
appears	NULL
to	NULL
be	NULL
required	NULL
for	NULL
mediating	NULL
IL-4-induced	NULL
Stat6	NULL
activation	NULL
.	NULL

Since	NULL
the	NULL
E1C3	NULL
cell	NULL
line	NULL
was	NULL
derived	NULL
by	NULL
mutagenesis	NULL
with	NULL
ethylmethane-sulfonate	NULL
(	NULL
31	NULL
)	NULL
,	NULL
it	NULL
remained	NULL
possible	NULL
that	NULL
other	NULL
functional	NULL
defects	NULL
could	NULL
account	NULL
for	NULL
the	NULL
inability	NULL
of	NULL
IL-4	NULL
to	NULL
mediate	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

There-fore	NULL
,	NULL
a	NULL
mammalian	NULL
expression	NULL
vector	NULL
containing	NULL
murine	NULL
Jakl	NULL
cDNA	NULL
was	NULL
transiently	NULL
transfected	NULL
into	NULL
E1C3	NULL
cells	NULL
(	NULL
E1C3/Jak1	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
revealed	NULL
that	NULL
Jakl	NULL
protein	NULL
levels	NULL
attained	NULL
in	NULL
E1C3/Jak1	NULL
cells	NULL
were	NULL
equivalent	NULL
to	NULL
those	NULL
in	NULL
1D4	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

The	NULL
E1C3/Jak1	NULL
transfected	NULL
cells	NULL
were	NULL
untreated	NULL
or	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Jak1	NULL
Requirement	NULL
for	NULL
IL-4	NULL
Signal	NULL
Transduction	NULL
6559	NULL
A	NULL
€	NULL
B	NULL
E1C3/Jak1	NULL
C	NULL
E1C3/Jaki1	NULL
Polke	NULL
)	NULL
__-_-_____	NULL
m	NULL
S	NULL
a	NULL
p	NULL
<	NULL
+	NULL
3	NULL
0	NULL
§	NULL
8	NULL
s	NULL
a	NULL
o	NULL
d	NULL
s	NULL
3	NULL
r	NULL
``	NULL
-	NULL
&	NULL
200	NULL
200	NULL
-	NULL
*	NULL
Jaki	NULL
>	NULL
@	NULL
*	NULL
_	NULL
@	NULL
w	NULL
»	NULL
IRS-1	NULL
»	NULL
#	NULL
i	NULL
(	NULL
p	NULL
<	NULL
IRS-2	NULL
97	NULL
-	NULL
<	NULL
Stat6	NULL
97	NULL
IP	NULL
:	NULL
anti-PY	NULL
_	NULL
anti-PY	NULL
IP	NULL
:	NULL
anti-Stat6	NULL
Blot	NULL
:	NULL
_	NULL
anti-Jak1	NULL
Blot	NULL
:	NULL
-	NULL
anti-lRS-1	NULL
anti-IRS-2	NULL
Blot	NULL
:	NULL
_	NULL
anti-PY	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Transient	NULL
expression	NULL
of	NULL
Jakl	NULL
in	NULL
E1C3	NULL
cells	NULL
restores	NULL
the	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
mediate	NULL
IRS-1	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
Stat6	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

E1C3	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
a	NULL
retroviral	NULL
expression	NULL
vector	NULL
containing	NULL
Jak1	NULL
cDNA	NULL
as	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

A	NULL
,	NULL
equivalent	NULL
amounts	NULL
of	NULL
proteins	NULL
from	NULL
lysates	NULL
of	NULL
1D4	NULL
,	NULL
E1C3	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
EIC3/Jak1	NULL
cells	NULL
were	NULL
immunoblotted	NULL
(	NULL
Blot	NULL
)	NULL
with	NULL
anti-Jak1	NULL
serum	NULL
,	NULL
as	NULL
designated	NULL
.	NULL

The	NULL
Jak1	NULL
protein	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrowhead	NULL
and	NULL
the	NULL
molecular	NULL
mass	NULL
marker	NULL
is	NULL
in	NULL
kilodaltons	NULL
.	NULL

B	NULL
,	NULL
EIC3/Jak1	NULL
cells	NULL
were	NULL
unstimulated	NULL
(	NULL
0	NULL
)	NULL
or	NULL
treated	NULL
with	NULL
IL-4	NULL
.	NULL

Lysates	NULL
were	NULL
immunoprecipitated	NULL
(	NULL
JP	NULL
)	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
anti-PY	NULL
)	NULL
and	NULL
immunoblotted	NULL
(	NULL
Blof	NULL
)	NULL
with	NULL
anti-IRS-1	NULL
or	NULL
anti-IRS-2	NULL
serum	NULL
or	NULL
C	NULL
,	NULL
immunoprecipitated	NULL
(	NULL
ZP	NULL
)	NULL
with	NULL
anti-Stat6	NULL
and	NULL
immunoblotted	NULL
(	NULL
Blot	NULL
)	NULL
with	NULL
anti-phosphotyrosine	NULL
(	NULL
anti-PY	NULL
)	NULL
.	NULL

stimulated	NULL
with	NULL
IL-4	NULL
and	NULL
IRS	NULL
,	NULL
and	NULL
Stat6	NULL
phosphorylation	NULL
was	NULL
examined	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
B	NULL
and	NULL
C	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS-1	NULL
,	NULL
IRS-2	NULL
,	NULL
and	NULL
Stat6	NULL
was	NULL
restored	NULL
in	NULL
the	NULL
E1C3/Jak1	NULL
transfected	NULL
cells	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
IL-4	NULL
to	NULL
induce	NULL
binding	NULL
of	NULL
Stat6	NULL
to	NULL
Ie	NULL
as	NULL
determined	NULL
by	NULL
EMSA	NULL
was	NULL
also	NULL
reconstituted	NULL
in	NULL
the	NULL
E1C3/Jak1	NULL
cells	NULL
.	NULL
``	NULL

These	NULL
data	NULL
provide	NULL
conclusive	NULL
evidence	NULL
that	NULL
Jak1	NULL
expression	NULL
is	NULL
required	NULL
for	NULL
mediating	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
both	NULL
IRS	NULL
and	NULL
Stat6	NULL
molecules	NULL
in	NULL
the	NULL
HeLa	NULL
cell	NULL
system	NULL
.	NULL

A	NULL
recent	NULL
study	NULL
demonstrated	NULL
that	NULL
Jak1	NULL
but	NULL
not	NULL
Jak2	NULL
or	NULL
Tyk2	NULL
expression	NULL
is	NULL
crucial	NULL
for	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS	NULL
molecules	NULL
in	NULL
a	NULL
series	NULL
of	NULL
mutant	NULL
derivatives	NULL
of	NULL
a	NULL
human	NULL
fibroblast	NULL
cell	NULL
line	NULL
,	NULL
HT	NULL
1080	NULL
(	NULL
37	NULL
)	NULL
.	NULL

E1C3	NULL
cells	NULL
express	NULL
Jak2	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
Tyk2	NULL
(	NULL
32	NULL
)	NULL
,	NULL
further	NULL
excluding	NULL
the	NULL
possibility	NULL
that	NULL
these	NULL
Janus	NULL
kinases	NULL
are	NULL
involved	NULL
in	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
cellular	NULL
substrates	NULL
.	NULL

However	NULL
,	NULL
our	NULL
results	NULL
do	NULL
not	NULL
rule	NULL
out	NULL
the	NULL
possibility	NULL
that	NULL
Fes	NULL
or	NULL
Jak3	NULL
may	NULL
be	NULL
capable	NULL
of	NULL
evoking	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
,	NULL
since	NULL
these	NULL
kinases	NULL
do	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
1D4	NULL
or	NULL
E1C3	NULL
lines	NULL
.	NULL

It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
Fes	NULL
expression	NULL
appears	NULL
to	NULL
be	NULL
limited	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
myeloid	NULL
lineage	NULL
(	NULL
88	NULL
)	NULL
.	NULL

Since	NULL
it	NULL
is	NULL
well	NULL
established	NULL
that	NULL
IL-4	NULL
affects	NULL
numerous	NULL
cell	NULL
types	NULL
other	NULL
than	NULL
those	NULL
of	NULL
myeloid	NULL
origin	NULL
,	NULL
the	NULL
role	NULL
of	NULL
Fes	NULL
in	NULL
mediating	NULL
IL-4-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
intracellular	NULL
substrates	NULL
would	NULL
be	NULL
severely	NULL
restricted	NULL
.	NULL

Jak3	NULL
is	NULL
also	NULL
preferentially	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
(	NULL
89	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
several	NULL
recent	NULL
studies	NULL
have	NULL
indicated	NULL
that	NULL
IL-2Ry	NULL
expression	NULL
is	NULL
not	NULL
necessarily	NULL
required	NULL
for	NULL
IL-4	NULL
function	NULL
(	NULL
40-43	NULL
)	NULL
.	NULL

Since	NULL
Jak3	NULL
has	NULL
been	NULL
demonstrated	NULL
to	NULL
associate	NULL
with	NULL
IL-2Ry	NULL
(	NULL
24	NULL
,	NULL
27	NULL
)	NULL
,	NULL
this	NULL
further	NULL
suggests	NULL
that	NULL
it	NULL
is	NULL
unlikely	NULL
that	NULL
Jak3	NULL
is	NULL
the	NULL
primary	NULL
kinase	NULL
utilized	NULL
by	NULL
IL-4	NULL
for	NULL
eliciting	NULL
its	NULL
biological	NULL
functions	NULL
.	NULL

We	NULL
are	NULL
presently	NULL
attempting	NULL
to	NULL
express	NULL
Jak3	NULL
and	NULL
Fes	NULL
in	NULL
the	NULL
E1C3	NULL
line	NULL
to	NULL
determine	NULL
if	NULL
these	NULL
kinases	NULL
can	NULL
mediate	NULL
IL-4-directed	NULL
tyrosine	NULL
phosphorylation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
a	NULL
variety	NULL
of	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
activate	NULL
Jak1	NULL
(	NULL
23	NULL
)	NULL
.	NULL

We	NULL
have	NULL
obtained	NULL
preliminary	NULL
evidence	NULL
that	NULL
interferon-	NULL
«	NULL
-	NULL
and	NULL
-y-induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS	NULL
molecules	NULL
requires	NULL
Jak1	NULL
expression	NULL
.	NULL

*	NULL
It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
other	NULL
cytokines	NULL
require	NULL
Jak1	NULL
to	NULL
direct	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
IRS	NULL
molecules	NULL
or	NULL
other	NULL
substrates	NULL
under	NULL
physiological	NULL
conditions	NULL
.	NULL

If	NULL
so	NULL
,	NULL
this	NULL
would	NULL
suggest	NULL
that	NULL
Jakl	NULL
plays	NULL
a	NULL
central	NULL
role	NULL
in	NULL
mediating	NULL
signal	NULL
transduction	NULL
through	NULL
multiple	NULL
non-tyrosine	NULL
kinase-con-taining	NULL
receptors	NULL
.	NULL

In	NULL
summary	NULL
,	NULL
our	NULL
study	NULL
strongly	NULL
suggests	NULL
that	NULL
Jak1	NULL
is	NULL
the	NULL
primary	NULL
kinase	NULL
that	NULL
couples	NULL
with	NULL
the	NULL
IL-4R	NULL
to	NULL
initiate	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
critical	NULL
effector	NULL
molecules	NULL
involved	NULL
in	NULL
mediating	NULL
IL-4	NULL
elicited	NULL
signal	NULL
transduction	NULL
.	NULL

*	NULL
B.	NULL
K.	NULL
R.	NULL
Patel	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

*X.	NULL
H.	NULL
Chen	NULL
,	NULL
B.	NULL
K.	NULL
R.	NULL
Patel	NULL
,	NULL
and	NULL
L.-M.	NULL
Wang	NULL
,	NULL
unpublished	NULL
data	NULL
.	NULL

a	NULL
m	NULL
to	NULL
10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

28.	NULL
.	NULL

Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Miura	NULL
,	NULL
O.	NULL
,	NULL
Lai	NULL
,	NULL
K.	NULL
S.	NULL
,	NULL
Cwik	NULL
,	NULL
C.	NULL
,	NULL
Lui	NULL
,	NULL
E.	NULL
T.	NULL
,	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

REFERENCES	NULL
.	NULL

Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1991	NULL
)	NULL
Blood	NULL
77	NULL
,	NULL
1859-1870	NULL
.	NULL

Lowenthal	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Castle	NULL
,	NULL
B.	NULL
E.	NULL
,	NULL
Christiansen	NULL
,	NULL
J.	NULL
,	NULL
Schreuers	NULL
,	NULL
J.	NULL
,	NULL
Rennick	NULL
,	NULL
D.	NULL
,	NULL
Arai	NULL
,	NULL
N.	NULL
,	NULL
Hoy	NULL
,	NULL
P.	NULL
,	NULL
Takebe	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Howard	NULL
,	NULL
M.	NULL
(	NULL
1988	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

140	NULL
,	NULL
456-465	NULL
.	NULL

Ohara	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
(	NULL
1987	NULL
)	NULL
Nature	NULL
825	NULL
,	NULL
537-539	NULL
.	NULL

Park	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
Friend	NULL
,	NULL
D.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Urdal	NULL
,	NULL
D.	NULL
L.	NULL
(	NULL
1987	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

84	NULL
,	NULL
1669-1672	NULL
.	NULL

Mosley	NULL
,	NULL
B.	NULL
,	NULL
Beckmann	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
March	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
Idzerda	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
Gimpel	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
VandenBos	NULL
,	NULL
T.	NULL
,	NULL
Friend	NULL
,	NULL
D.	NULL
,	NULL
Alpert	NULL
,	NULL
A.	NULL
,	NULL
Anderson	NULL
,	NULL
D.	NULL
,	NULL
Jackson	NULL
,	NULL
J.	NULL
,	NULL
Wignal	NULL
,	NULL
J.	NULL
,	NULL
Smith	NULL
,	NULL
C.	NULL
,	NULL
Gallis	NULL
,	NULL
B.	NULL
,	NULL
Sims	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Urdal	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Widmer	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Cosman	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Park	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
59	NULL
,	NULL
335-344	NULL
.	NULL

Idzerda	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
March	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
Mosley	NULL
,	NULL
B.	NULL
,	NULL
Lyman	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
VandenBos	NULL
,	NULL
T.	NULL
,	NULL
Gimpel	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Din	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Widmer	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
and	NULL
Park	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1990	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171	NULL
,	NULL
861-876	NULL
.	NULL

Kondo	NULL
,	NULL
M.	NULL
,	NULL
Takeshita	NULL
,	NULL
T.	NULL
,	NULL
Ishii	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
M.	NULL
,	NULL
Watanabe	NULL
,	NULL
S.	NULL
,	NULL
Arai	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sugamura	NULL
,	NULL
K.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1874-1877	NULL
.	NULL

Russel	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Harada	NULL
,	NULL
N.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
,	NULL
Leland	NULL
,	NULL
P.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
Puri	NULL
,	NULL
R.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Leonard	NULL
,	NULL
W.	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1874-1877	NULL
.	NULL

Morla	NULL
,	NULL
A.	NULL
O.	NULL
,	NULL
Schreurs	NULL
,	NULL
J.	NULL
,	NULL
Miyajima	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Wang	NULL
,	NULL
J.	NULL
Y	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

88	NULL
,	NULL
2214-2221	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
Heidaran	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Gutkind	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
and	NULL
Pierce	NULL
J.	NULL
H.	NULL
(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
4899-4908	NULL
Tzubhara	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Harada	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
13097-13102	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Li	NULL
,	NULL
W.	NULL
,	NULL
Lienhard	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Pacini	NULL
,	NULL
S.	NULL
,	NULL
Gutkind	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
Myers	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Sun	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Aaronson	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

90	NULL
,	NULL
4032-4036	NULL
Hou	NULL
,	NULL
J.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Henzel	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
Ho	NULL
,	NULL
T.	NULL
C.	NULL
,	NULL
Brasseur	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
McKnight	NULL
,	NULL
S.	NULL
L.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1701-1706	NULL
Kotanides	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
Reich	NULL
,	NULL
N.	NULL
C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
262	NULL
,	NULL
1265-1267	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Shimoda	NULL
,	NULL
K.	NULL
,	NULL
Thierfelder	NULL
,	NULL
W.	NULL
,	NULL
Fischer	NULL
,	NULL
C.	NULL
,	NULL
Kim	NULL
,	NULL
A.	NULL
,	NULL
Ruben	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Cleveland	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
Keegan	NULL
,	NULL
A.	NULL
D.	NULL
,	NULL
Nelms	NULL
,	NULL
K.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
3336-3343	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Kashleva	NULL
,	NULL
H.	NULL
,	NULL
Pernis	NULL
,	NULL
A.	NULL
,	NULL
Pine	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Rothman	NULL
,	NULL
P.	NULL
(	NULL
1994	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

18	NULL
,	NULL
1350-1356	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Myers	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Sun	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Aaronson	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
261	NULL
,	NULL
1591-1594	NULL
Sun	NULL
,	NULL
X.	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Zhang	NULL
,	NULL
Y.	NULL
,	NULL
Lynne	NULL
,	NULL
Y.	NULL
,	NULL
Myers	NULL
,	NULL
M.	NULL
G.	NULL
,	NULL
Glasheen	NULL
,	NULL
E.	NULL
,	NULL
Lane	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
(	NULL
1995	NULL
)	NULL
Nature	NULL
877	NULL
,	NULL
178-177	NULL
Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Schindler	NULL
,	NULL
U.	NULL
,	NULL
Smiley	NULL
,	NULL
S.	NULL
T.	NULL
,	NULL
and	NULL
Grusby	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Immunity	NULL
4	NULL
,	NULL
1-20	NULL
Takeda	NULL
,	NULL
K.	NULL
,	NULL
Tanaka	NULL
,	NULL
T.	NULL
,	NULL
Wei	NULL
,	NULL
S.	NULL
,	NULL
Matsumoto	NULL
,	NULL
M.	NULL
,	NULL
Minami	NULL
,	NULL
M.	NULL
,	NULL
Kashiwamura	NULL
,	NULL
S-L.	NULL
,	NULL
Nakanish	NULL
,	NULL
K.	NULL
,	NULL
Yoshida	NULL
,	NULL
N.	NULL
,	NULL
Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Akira	NULL
,	NULL
S.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
380	NULL
,	NULL
627-630	NULL
Shimoda	NULL
,	NULL
K.	NULL
,	NULL
van	NULL
Deursen	NULL
,	NULL
J.	NULL
,	NULL
Sangster	NULL
,	NULL
M.	NULL
Y.	NULL
,	NULL
Sarawar	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Carson	NULL
,	NULL
R.	NULL
T.	NULL
,	NULL
Tripp	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Chu	NULL
,	NULL
C.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Nosaka	NULL
,	NULL
T.	NULL
,	NULL
Vignali	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
Doherty	NULL
,	NULL
P.	NULL
C.	NULL
,	NULL
Grosveld	NULL
,	NULL
G.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
880	NULL
,	NULL
630-633	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Kerr	NULL
,	NULL
I.	NULL
M.	NULL
(	NULL
1995	NULL
)	NULL
Trends	NULL
Genet	NULL
.	NULL

11	NULL
,	NULL
8951-3963	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Darnell	NULL
,	NULL
J.	NULL
E.	NULL
(	NULL
1995	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64	NULL
,	NULL
621-651	NULL
and	NULL
Thle	NULL
,	NULL
J.	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
Nature	NULL
870	NULL
,	NULL
158-157	NULL
Russel	NULL
,	NULL
S.	NULL
M.	NULL
,	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Noguchi	NULL
,	NULL
M.	NULL
N.	NULL
,	NULL
Kawamura	NULL
,	NULL
M.	NULL
,	NULL
Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Friedmann	NULL
,	NULL
M.	NULL
,	NULL
Berg	NULL
,	NULL
M.	NULL
,	NULL
McVicar	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
Witthun	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Silvennoinen	NULL
,	NULL
O.	NULL
,	NULL
Goldman	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
and	NULL
Schmalstieg	NULL
,	NULL
F.	NULL
C.	NULL
(	NULL
1995	NULL
)	NULL
Science	NULL
266	NULL
,	NULL
1042-1045	NULL
Yin	NULL
,	NULL
T.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
L.-S.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
26614-26617	NULL
Izuhara	NULL
,	NULL
K.	NULL
,	NULL
Feldman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Greer	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Harada	NULL
,	NULL
N.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269	NULL
,	NULL
18623-18629	NULL
Murata	NULL
,	NULL
T	NULL
,	NULL
Noguchi	NULL
P.	NULL
D.	NULL
,	NULL
and	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
30829-30836	NULL
Yin	NULL
,	NULL
T.	NULL
,	NULL
Keller	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
Quelle	NULL
,	NULL
F.	NULL
W.	NULL
,	NULL
Witthuhn	NULL
,	NULL
B	NULL
.	NULL

A.	NULL
,	NULL
Tsang	NULL
,	NULL
M.	NULL
L.-S.	NULL
,	NULL
Lienhard	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
Thile	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
Yang	NULL
,	NULL
Y.-C.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
20497-20502	NULL
Johnston	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Hanson	NULL
,	NULL
E.	NULL
P.	NULL
,	NULL
Sun	NULL
,	NULL
X.-J	NULL
.	NULL

,	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
Oakes	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
O'Shea	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
28527-28530	NULL
Loh	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Chang	NULL
,	NULL
C.-H.	NULL
,	NULL
Fodor	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
1351-1363	NULL
Loh	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Schindler	NULL
,	NULL
C.	NULL
,	NULL
Ziemiecki	NULL
,	NULL
A.	NULL
,	NULL
Harpur	NULL
,	NULL
A.	NULL
G.	NULL
,	NULL
Wilks	NULL
,	NULL
A.	NULL
F.	NULL
,	NULL
and	NULL
Flavell	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
2170-2179	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
6560	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

Patel	NULL
,	NULL
B.	NULL
K.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Lee	NULL
,	NULL
C.-C.	NULL
,	NULL
Taylor	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
LaRochelle	NULL
,	NULL
W.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
22175-22182	NULL
Gustafson	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
He	NULL
.	NULL

W.	NULL
,	NULL
Craparo	NULL
,	NULL
A.	NULL
,	NULL
Schaub	NULL
,	NULL
C.	NULL
D.	NULL
,	NULL
and	NULL
O'Neill	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
,	NULL
2500-2508	NULL
He	NULL
,	NULL
W.	NULL
,	NULL
Craparo	NULL
,	NULL
A.	NULL
,	NULL
Zhu	NULL
,	NULL
Y.	NULL
,	NULL
O'Neill	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
Wang	NULL
,	NULL
L.-M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
H.	NULL
,	NULL
and	NULL
Gustafson	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
11641-11645	NULL
Sawka-Verhelle	NULL
,	NULL
D.	NULL
,	NULL
Tartare-Deckert	NULL
,	NULL
S.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
F.	NULL
,	NULL
and	NULL
Van	NULL
Obberghen	NULL
,	NULL
E.	NULL
(	NULL
1996	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
,	NULL
5980-5983	NULL
Wang	NULL
,	NULL
H.	NULL
Y.	NULL
,	NULL
Zamorano	NULL
,	NULL
J.	NULL
,	NULL
Yoerkie	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Paul	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
and	NULL
Keegan	NULL
A.	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
,	NULL
1037-1040	NULL
Feldman	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
Gabrilove	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Tam	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
Moore	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Hanafusa	NULL
,	NULL
H.	NULL
42	NULL
43	NULL
Jak1	NULL
Requirement	NULL
for	NULL
IL-4	NULL
Signal	NULL
Transduction	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

82	NULL
,	NULL
2879-2383	NULL
.	NULL

Gurniak	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
and	NULL
Berg	NULL
,	NULL
L.	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Blood	NULL
87	NULL
,	NULL
3151-3160	NULL
.	NULL

Matthews	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
Clark	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Herbert	NULL
,	NULL
J.	NULL
,	NULL
Morgan	NULL
,	NULL
G.	NULL
,	NULL
Armitage	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
Kinnon	NULL
,	NULL
C.	NULL
,	NULL
Minty	NULL
,	NULL
A.	NULL
,	NULL
Grabstein	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Caput	NULL
,	NULL
D.	NULL
,	NULL
Ferrara	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Callard	NULL
,	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Blood	NULL
85	NULL
,	NULL
1-7	NULL
.	NULL

Obiri	NULL
,	NULL
N.	NULL
I.	NULL
,	NULL
Debinski	NULL
,	NULL
W.	NULL
,	NULL
Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
Puri	NULL
,	NULL
R.	NULL
K.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
8797-8804	NULL
.	NULL

He	NULL
,	NULL
Y-W.	NULL
,	NULL
Adkins	NULL
,	NULL
B.	NULL
,	NULL
Furse	NULL
,	NULL
R.	NULL
K.	NULL
,	NULL
and	NULL
Malek	NULL
,	NULL
T.	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

154	NULL
,	NULL
1596-1604	NULL
.	NULL

Lai	NULL
,	NULL
S.	NULL
Y.	NULL
,	NULL
Molden	NULL
,	NULL
J.	NULL
,	NULL
Liu	NULL
,	NULL
K.	NULL
D.	NULL
,	NULL
White	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
Goldsmith	NULL
,	NULL
M.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

15	NULL
,	NULL
4506-4514	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
/810-0q	NULL
[	NULL
'mmmy/	NULL
:	NULL
dyy	NULL
wo	NULL
;	NULL
popeoumog	NULL
Jak1	NULL
Expression	NULL
Is	NULL
Required	NULL
for	NULL
Mediating	NULL
Interleukin-4-induced	NULL
Tyrosine	NULL
Phosphorylation	NULL
of	NULL
Insulin	NULL
Receptor	NULL
Substrate	NULL
and	NULL
Stat6	NULL
Signaling	NULL
Molecules	NULL
Xiao	NULL
Hong	NULL
Chen	NULL
,	NULL
Bharvin	NULL
K.	NULL
R.	NULL
Patel	NULL
,	NULL
Ling-Mei	NULL
Wang	NULL
,	NULL
Mark	NULL
Frankel	NULL
,	NULL
Nelson	NULL
Ellmore	NULL
,	NULL
Richard	NULL
A.	NULL
Flavell	NULL
,	NULL
William	NULL
J.	NULL
LaRochelle	NULL
and	NULL
Jacalyn	NULL
H.	NULL
Pierce	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1997	NULL
,	NULL
272:6556-6560.	NULL
doi	NULL
:	NULL
10.1074/jb0.272.10.6556	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/272/10/6556	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
43	NULL
references	NULL
,	NULL
28	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
0/6556	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
4g	NULL
wo	NULL
;	NULL
popeoumog	NULL

